Mangoceuticals, Inc.
MGRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $84 | $168 | $109 | $105 |
| % Growth | -49.9% | 53.8% | 3.9% | – |
| Cost of Goods Sold | $33 | $78 | $47 | $25 |
| Gross Profit | $51 | $90 | $62 | $80 |
| % Margin | 60.4% | 53.5% | 56.8% | 76.1% |
| R&D Expenses | $0 | $0 | $0 | $172 |
| G&A Expenses | $311 | $4,994 | $3,215 | $1,596 |
| SG&A Expenses | $416 | $5,252 | $3,496 | $1,742 |
| Sales & Mktg Exp. | $105 | $258 | $282 | $146 |
| Other Operating Expenses | $7,178 | $106 | $1,419 | -$156 |
| Operating Expenses | $7,594 | $5,358 | $4,915 | $1,758 |
| Operating Income | -$7,543 | -$5,268 | -$4,853 | -$1,678 |
| % Margin | -8,953.5% | -3,134% | -4,440% | -1,594.3% |
| Other Income/Exp. Net | -$76 | -$147 | $14 | -$271 |
| Pre-Tax Income | -$7,619 | -$5,416 | -$4,839 | -$1,949 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$7,618 | -$5,416 | -$4,839 | -$1,948 |
| % Margin | -9,042.8% | -3,221.6% | -4,427.4% | -1,850.9% |
| EPS | -0.69 | -0.54 | -1.054 | -0.6 |
| % Growth | -27.8% | 48.7% | -75.5% | – |
| EPS Diluted | -0.69 | -0.54 | -1.054 | -0.6 |
| Weighted Avg Shares Out | 11,524 | 9,983 | 4,593 | 3,246 |
| Weighted Avg Shares Out Dil | 11,524 | 9,983 | 4,593 | 3,246 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $14 | $0 |
| Interest Expense | $76 | $22 | $0 | -$451 |
| Depreciation & Amortization | $25 | $836 | $415 | $722 |
| EBITDA | -$7,518 | -$4,558 | -$4,438 | -$1,677 |
| % Margin | -8,924% | -2,711.3% | -4,060.3% | -1,593.4% |